杆菌和胃癌:当前的见解和基于纳米粒子的干预措施
Syed Ali Raza Shah1, Maria Mumtaz1, Sumaira Sharif1
1Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore Lahore Pakistan ali.raza@imbb.uol.edu.pk.
RSC advances
|February 19, 2025
概括
杆菌 (H. pylori) 感染通过分子变化驱动胃癌. 纳米粒子疗法在治疗H. pylori诱导的胃癌方面表现有前途,改善药物输送和免疫反应.
科学领域:
- 胃肠道学和瘤学
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 杆菌 (H. pylori) 是胃癌的主要原因,是全球癌症死亡的主要原因.
- 了解H. pylori在胃癌发生中的作用对于制定有效的预防策略至关重要.
研究的目的:
- 审查有关H. pylori和胃癌的当前文献.
- 专注于分子机制,基于纳米粒子的疗法和临床进展.
主要方法:
- 在PubMed,谷歌学者和科学网上进行全面的文献搜索.
- 包括从2010年到2024年的研究.
- 对H. pylori,胃癌,纳米粒子和治疗干预措施的研究结果的综合.
主要成果:
- 杆菌感染诱导慢性炎症,DNA变化,表观遗传变化和瘤路径激活,导致胃癌.
- 传统的抗生素治疗因抗生素耐药性增加而面临挑战.
- 纳米粒子配方 (基于脂质,聚合物,金属) 正在研究,通过改善药物输送和调节免疫反应来增强H. pylori治疗.
结论:
- 基于纳米颗粒的干预措施代表了在管理H. pylori诱导的胃癌中药物输送的有希望的战略.
- 需要进一步的研究和临床试验,以将这些纳米医学发现转化为H. pylori相关的胃恶性瘤的临床实践.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
319
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
319
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
79
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
79
Peptic Ulcer Disease IV: Management
60
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
60
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Gastritis III: Clinical Manifestations and Management
124
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
124
Peptic Ulcer Disease I: Introduction
119
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
119


